Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)

Detalles Bibliográficos
Autores principales: Boschi, Céline, Colson, Philippe, Bancod, Audrey, Moal, Valérie, La Scola, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402686/
https://www.ncbi.nlm.nih.gov/pubmed/35171987
http://dx.doi.org/10.1093/cid/ciac143
_version_ 1784773216484458496
author Boschi, Céline
Colson, Philippe
Bancod, Audrey
Moal, Valérie
La Scola, Bernard
author_facet Boschi, Céline
Colson, Philippe
Bancod, Audrey
Moal, Valérie
La Scola, Bernard
author_sort Boschi, Céline
collection PubMed
description
format Online
Article
Text
id pubmed-9402686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-94026862022-08-25 Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC) Boschi, Céline Colson, Philippe Bancod, Audrey Moal, Valérie La Scola, Bernard Clin Infect Dis Correspondence Oxford University Press 2022-02-16 /pmc/articles/PMC9402686/ /pubmed/35171987 http://dx.doi.org/10.1093/cid/ciac143 Text en © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Boschi, Céline
Colson, Philippe
Bancod, Audrey
Moal, Valérie
La Scola, Bernard
Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title_full Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title_fullStr Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title_full_unstemmed Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title_short Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
title_sort omicron variant escapes therapeutic monoclonal antibodies (mabs) including recently released evusheld(®), contrary to 8 prior main variant of concern (voc)
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402686/
https://www.ncbi.nlm.nih.gov/pubmed/35171987
http://dx.doi.org/10.1093/cid/ciac143
work_keys_str_mv AT boschiceline omicronvariantescapestherapeuticmonoclonalantibodiesmabsincludingrecentlyreleasedevusheldcontraryto8priormainvariantofconcernvoc
AT colsonphilippe omicronvariantescapestherapeuticmonoclonalantibodiesmabsincludingrecentlyreleasedevusheldcontraryto8priormainvariantofconcernvoc
AT bancodaudrey omicronvariantescapestherapeuticmonoclonalantibodiesmabsincludingrecentlyreleasedevusheldcontraryto8priormainvariantofconcernvoc
AT moalvalerie omicronvariantescapestherapeuticmonoclonalantibodiesmabsincludingrecentlyreleasedevusheldcontraryto8priormainvariantofconcernvoc
AT lascolabernard omicronvariantescapestherapeuticmonoclonalantibodiesmabsincludingrecentlyreleasedevusheldcontraryto8priormainvariantofconcernvoc

Ejemplares similares